Plasma amyloid assay as a pre-screening tool for amyloid positron emission tomography imaging in early stage Alzheimer’s disease

Overview of attention for article published in Alzheimer's Research & Therapy, December 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (77th percentile)

Mentioned by

news: 1 news outlet

Citations

dimensions_citation: 19 Dimensions

Readers on

mendeley: 47 Mendeley

Summary News Dimensions citations

So far, Dimensions has found 19 publications that cite this research output.

19

The most recent citing publications are shown below. View all 19 publications that cite this research output on Dimensions.

Vascular Risk Predicts Plasma Amyloid β 42/40 Through Cerebral Amyloid Burden in Apolipoprotein E ε4 Carriers

Article in Stroke (April 2023)

Research progress of PPARγ regulation of cholesterol and inflammation in Alzheimer's disease

Article in Metabolic Brain Disease (February 2023)

Immunosenescence and Aging: Neuroinflammation Is a Prominent Feature of Alzheimer’s Disease and Is a Likely Contributor to Neurodegenerative Disease Pathogenesis

Article in Journal of Personalized Medicine (November 2022)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.